Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page history shows a new revision label Revision: v3.3.2 added and the prior Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedA new site revision entry (Revision: v3.3.1) was added and the previous revision (Revision: v3.2.0) was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedNotice about government funding lapse and potential data delays was removed from the page.SummaryDifference0.8%

- Check38 days agoChange DetectedA new history entry dated 2022-06-13 was added, updating the Study Status and referencing prior Recruitment Status changes in the record.SummaryDifference0.1%

- Check67 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference13%

- Check74 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.